Exploring new immune signals to enhance cancer treatment
Discovery of diverse nucleotide immune signals for use as novel immunotherapies
This study is looking at ways to boost cancer treatments by using natural signals to help your immune system better fight tumors, which could lead to new therapies that make your body more effective at recognizing and attacking cancer cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11093482 on NIH RePORTER |
What this research studies
This research investigates how to improve cancer immunotherapy by using natural signals that stimulate the immune system. The focus is on overcoming the challenges posed by the tumor microenvironment, which often suppresses immune responses. By activating a specific immune pathway known as cGAS-STING, the research aims to enhance the body's ability to recognize and attack tumor cells. Patients may benefit from new therapies that could make their immune systems more effective against cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who may benefit from enhanced immune responses against their tumors.
Not a fit: Patients with non-cancerous conditions or those whose tumors are not responsive to immune therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel immunotherapies that significantly improve cancer treatment outcomes.
How similar studies have performed: Other research has shown promise in using immune signaling pathways to enhance cancer treatment, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: Slavik, Kailey — Rockefeller University
- Study coordinator: Slavik, Kailey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.